These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33493994)

  • 1. Utilization of lysis percentage via thromboelastography for tissue plasminogen activator-induced symptomatic intracranial hemorrhage.
    Gilbert BW; Dingman JS; Huffman JB
    Am J Emerg Med; 2021 May; 43():31-34. PubMed ID: 33493994
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis related symptomatic intracranial hemorrhage in estimated versus measured body weight.
    Truc My Nguyen T; van de Stadt SI; Groot AE; Wermer MJ; den Hertog HM; Droste HM; van Zwet EW; van Schaik SM; Coutinho JM; Kruyt ND
    Int J Stroke; 2020 Feb; 15(2):159-166. PubMed ID: 31092150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter by Dai et al regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
    Dai Q; Sun W; Liu X
    Stroke; 2014 Jul; 45(7):e132. PubMed ID: 24916904
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to letter regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
    Whiteley WN; Thompson D; Sandercock P
    Stroke; 2014 Jul; 45(7):e133. PubMed ID: 24916910
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupat P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2622-2629. PubMed ID: 28826584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Mimics and Acute Stroke Evaluation: Clinical Differentiation and Complications after Intravenous Tissue Plasminogen Activator.
    Nguyen PL; Chang JJ
    J Emerg Med; 2015 Aug; 49(2):244-52. PubMed ID: 25802155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator-induced reperfusion injury after stroke revisited.
    Hermann DM; Matter CM
    Circulation; 2007 Jul; 116(4):363-5. PubMed ID: 17646593
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
    Suzuki Y; Nagai N; Umemura K
    J Pharmacol Sci; 2011; 116(1):25-9. PubMed ID: 21498957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Parameters for Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in an Asian Population.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupatand P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    Curr Neurovasc Res; 2017; 14(2):169-176. PubMed ID: 28356002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic hemorrhage after alteplase therapy not due to silent ischemia.
    Hill MD; Barber PA; Demchuk AM; Sevick RJ; Frayne R; Buchan AM
    BMC Neurol; 2001 Dec; 1():1. PubMed ID: 11208259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
    Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
    Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
    [No Abstract]   [Full Text] [Related]  

  • 16. Clot activators do not expedite the time to predict massive transfusion in trauma patients analyzed with tissue plasminogen activator thrombelastography.
    Walker CB; Moore EE; Kam A; Dexter-Meldrum J; Nydam TL; Chapman MP; Chandler J; Sauaia A; Barrett CD; Yaffe MB; Moore HB
    Surgery; 2019 Sep; 166(3):408-415. PubMed ID: 31230841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilateral intracranial hemorrhage following thrombolytic therapy with alteplase (rTPA) in acute myocardial infarction].
    Arbol Linde F; Marcos Sánchez F; Merlo González V; Simón Martín A; Quintana Díaz M; López Onega P
    An Med Interna; 2002 Nov; 19(11):605-6. PubMed ID: 12522906
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of tissue-type plasminogen activator in ischemic stroke.
    Suzuki Y
    J Pharmacol Sci; 2010; 113(3):203-7. PubMed ID: 20595786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain hemorrhage after thrombolysis: good or bad?
    von Kummer R
    Stroke; 2002 Jun; 33(6):1446-7. PubMed ID: 12052965
    [No Abstract]   [Full Text] [Related]  

  • 20. PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
    Szegedi I; Nagy A; Székely EG; Czuriga-Kovács KR; Sarkady F; Lánczi LI; Berényi E; Csiba L; Bagoly Z
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2240-2250. PubMed ID: 31637872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.